Using Three Different Doses of Hyperbaric Prilocaine 2% Local Anaesthetic ( 40,50 and 60mg ),Through Spinal Anaesthesia in Knee Arthroscopy Patients to Compare Time to Void

Launched by CAIRO UNIVERSITY · Nov 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how different doses of a local anesthetic called hyperbaric prilocaine can affect the time it takes for patients to go to the bathroom after knee surgery. The researchers are testing three doses (40mg, 50mg, and 60mg) in patients who are having a procedure called knee arthroscopy, which is a common type of surgery done on the knee. The main focus is to see which dose helps patients regain their ability to urinate the fastest after receiving spinal anesthesia.

To be eligible for this study, participants should be adults between 18 and 60 years old who are generally healthy and scheduled for knee arthroscopy. However, certain conditions like bleeding disorders, infections, or allergies to prilocaine may prevent someone from joining the study. Participants can expect to be monitored for any side effects, such as itching or nausea, and the researchers will also look at how quickly patients recover their movement and sensation after the procedure. This study is currently recruiting participants, and their findings could help improve care for patients undergoing similar surgeries in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients (male/female, American Society of Anesthesiologists physical status I-II, age: 18-60 years) undergoing knee arthroscopy will be eligible for the study. -
• Exclusion Criteria:
• • 1. Coagulopathy and other bleeding disorders (INR more than 1.4 and platelet less than 80000)
• • 2. Patient refusal.
• • 3. Infection at the site of injection.
• • 4. Allergies against prilocaine.
• • 5. Increased intracranial pressure.
• • 6. Severe MS and AS.
• • 7. Sever hypovolemia.